Clinical Trials Browser

peginterferon alfa-2a × Dermatologic × 90 days × Clear all

NCT07288112 2026-04-14

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Phase 1/2 Recruiting

Melanoma